Evidence & transparency
Research library
We publish the science behind every compound — mechanism summaries, peer-reviewed references, and batch-specific Certificates of Analysis you can download and verify.
Certificates of Analysis
16 batchesIndependent third-party HPLC testing. Each row links to the full signed PDF.
| Product | Lot | Purity | Method | Date | COA |
|---|---|---|---|---|---|
| Retatrutide | RET750 Freedom Diagnostics | 99.01% | HPLC-UV / LC-MS | 2026-05 | Download ↓ |
| Retatrutide | RET892 Freedom Diagnostics | 99.23% | HPLC-UV / LC-MS | 2026-05 | Download ↓ |
| Retatrutide | 260121-BZT-RT10-01-P Vanguard Laboratory (ISO 17025) | 99.44% | HPLC-UV/VIS | 2026-02 | Download ↓ |
| Retatrutide | BG4MA Vanguard Laboratory (ISO 17025) | 99.80% | HPLC-UV/VIS | 2026-02 | Download ↓ |
| Retatrutide | RET-260210-B1 Testides | 99.68% | HPLC-UV | 2026-02 | Download ↓ |
| NAD+ | 251212-BZT-NJ500-01 Vanguard Laboratory (ISO 17025) | 99.22% | HPLC-UV/VIS | 2026-02 | Download ↓ |
| GHK-Cu | 260121-BZT-CU50-01-P Vanguard Laboratory (ISO 17025) | 99.80% | HPLC-UV/VIS | 2026-02 | Download ↓ |
| CJC-1295 + Ipamorelin | 251215-LUL-CP10-01 Vanguard Laboratory (ISO 17025) | 99.32% | HPLC-UV/VIS | 2026-02 | Download ↓ |
| Tesamorelin | MJBTS Vanguard Laboratory (ISO 17025) | 99.06% | HPLC-UV/VIS | 2025-11 | Download ↓ |
| MOTS-c | JE020126S1 Freedom Diagnostics | 99.90% | HPLC-UV / MS | 2026-02 | Download ↓ |
| MOTS-c | TB122525S1 Freedom Diagnostics | 99.42% | HPLC-UV / MS | 2025-12 | Download ↓ |
| KLOW Blend | 251212-BZT-KL80-01 Vanguard Laboratory (ISO 17025) | 99.50% | HPLC-UV/VIS | 2026-01 | Download ↓ |
| KLOW Blend | M1-010120262028 Testides | 99.83% | HPLC-UV | 2026-02 | Download ↓ |
| GLOW Blend | B3TFL Kovera Labs | 99.68% | RP-HPLC / LC-MS | 2026-02 | Download ↓ |
| PT-141 | P41-260723 | 99.43% | HPLC-UV / LC-MS | 2026-07 | Download ↓ |
| Bacteriostatic Water | 0C261759 Bioviridian | 99.6% | RP-HPLC / MALDI-MS | 2026-05 | Download ↓ |
Clinical & mechanistic references
Retatrutide
Product →- 1.Jastreboff AM, et al. Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial. N Engl J Med. 2023.
- 2.Coskun T, et al. LY3437943, a novel triple GIP/GLP-1/glucagon receptor agonist. Cell Metab. 2022.
NAD+
Product →- 1.Rajman L, Chwalek K, Sinclair DA. Therapeutic Potential of NAD-Boosting Molecules. Cell Metab. 2018.
GHK-Cu
Product →- 1.Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide. Int J Mol Sci. 2018.
CJC-1295 + Ipamorelin
Product →- 1.Teichman SL, et al. Prolonged stimulation of GH and IGF-I secretion by CJC-1295, a long-acting GHRH analog. J Clin Endocrinol Metab. 2006.
- 2.Raun K, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998.
Tesamorelin
Product →- 1.Falutz J, et al. Metabolic effects of a growth hormone-releasing factor (tesamorelin) in patients with excess abdominal fat. N Engl J Med. 2007.
MOTS-c
Product →- 1.Lee C, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015.
KLOW Blend
Product →- 1.Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide. Int J Mol Sci. 2018.
- 2.Sikiric P, et al. Stable gastric pentadecapeptide BPC 157 — research overview. Curr Pharm Des. 2018.
GLOW Blend
Product →- 1.Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide. Int J Mol Sci. 2018.
- 2.Sikiric P, et al. Stable gastric pentadecapeptide BPC 157 — research overview. Curr Pharm Des. 2018.
DSIP
Product →- 1.Kovalzon VM, Strekalova TV. Delta sleep-inducing peptide (DSIP): a still unresolved riddle. J Neurochem. 2006.
Epitalon
Product →- 1.Khavinson VK, et al. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bull Exp Biol Med. 2003.
Semax
Product →- 1.Dolotov OV, et al. Semax, an analog of ACTH(4–10), increases BDNF expression in the rat hippocampus. Neurosci Lett. 2006.
Selank
Product →- 1.Zozulya AA, et al. Efficacy and safety of Selank in the therapy of generalized anxiety disorder. Zh Nevrol Psikhiatr Im S S Korsakova. 2008.
SS-31
Product →- 1.Szeto HH. First-in-class cardiolipin-protective compound as a therapeutic agent to reverse mitochondrial dysfunction (SS-31 / elamipretide). Br J Pharmacol. 2014.
PT-141
Product →- 1.Molinoff PB, Shadiack AM, Earle D, Diamond LE, Quon CY. PT-141: a melanocortin agonist for the treatment of sexual dysfunction. Ann N Y Acad Sci. 2003.
- 2.Kingsberg SA, Clayton AH, Portman D, et al. Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials. Obstet Gynecol. 2019.